Hostname: page-component-745bb68f8f-s22k5 Total loading time: 0 Render date: 2025-01-22T16:03:02.561Z Has data issue: false hasContentIssue false
  • English
  • Français

PROGRESS IN CLINICAL NEUROSCIENCES: Charcot-Marie-Tooth Disease and Related Inherited Peripheral Neuropathies

Published online by Cambridge University Press:  02 December 2014

Timothy J. Benstead  and
Ian A. Grant
Timothy J. Benstead
Affiliation:
Division of Neurology, QEII Health Sciences Centre and Dalhousie, University Medical School, Halifax, Nova Scotia, Canada
Ian A. Grant
Affiliation:
Division of Neurology, QEII Health Sciences Centre and Dalhousie, University Medical School, Halifax, Nova Scotia, Canada
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The classification of Charcot-Marie-Tooth disease and related hereditary motor and sensory neuropathies has evolved to incorporate clinical, electrophysiological and burgeoning molecular genetic information that characterize the many disorders. For several inherited neuropathies, the gene product abnormality is known and for others, candidate genes have been identified. Genetic testing can pinpoint a specific inherited neuropathy for many patients. However, clinical and electrophysiological assessments continue to be essential tools for diagnosis and management of this disease group. This article reviews clinical, electrophysiological, pathological and molecular aspects of hereditary motor and sensory neuropathies.

Résumé:

RÉSUMÉ:

La classification de la maladie de Charcot-Marie-Tooth et des neuropathies sensitivo-motrices hé;ré;ditaires apparenté;es a é;té; é;largie afin d'inclure l'information clinique, é;lectrophysiologique et molé;culaire qui caracté;rise ces entité;s. L'anomalie du gène et de la proté;ine en cause est connue dans plusieurs neuropathies hé;ré;ditaires alors que dans d'autres des gènes candidats ont é;té; identifié;s. Chez plusieurs patients, des tests gé;né;tiques peuvent identifier une neuropathies hé;ré;ditaire spé;cifique. Cependant, l'é;valuation clinique et é;lectrophysiologique demeure l'outil essentiel pour le diagnostic et la prise en charge de ce groupe de maladies. Cet article revoit les aspects cliniques, é;lectrophysiologiques, anatomopathologiques et molé;culaires des neuropathies sensitivo-motrices.

Type
Review Article
Information
Canadian Journal of Neurological Sciences , Volume 28 , Issue 3 , August 2001 , pp. 199 - 214
Copyright
Copyright © The Canadian Journal of Neurological 2001

References

1. Skre, H. Genetic and clinical aspects of Charcot-Marie-Tooth’s disease. Clin Genet 1974;6(2):98–118.Google Scholar
2. Combarros, O, Calleja, J, Polo, JM, Berciano, J. Prevalence ofhereditary motor and sensory neuropathy in Cantabria. Acta Neurol Scand 1987;75(1):9–12.Google Scholar
3. Holmberg, BH. Charcot-Marie-Tooth disease in northern Sweden:an epidemiological and clinical study. Acta Neurol Scand 1993;87(5):416–422.Google Scholar
4. Lupski, JR, Chance, PF, Garcia, CA. Inherited primary peripheralneuropathies. Molecular genetics and clinical implications of CMT 1A and HNPP. JAMA 1993;270(19):2326–2330.Google Scholar
5. Dyck, PJ, Lambert, EH. Lower motor and primary sensory neurondiseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol 1968;18(6):603–618.Google Scholar
6. Coutinho, P, Barros, J, Zemmouri, R, et al. Clinical heterogeneity ofautosomal recessive spastic paraplegias: analysis of 106 patientsin 46 families. Arch Neurol 1999;56(8):943–949.Google Scholar
7. Schelhaas, HJ, Hulst, MV, Ippel, E, Prevo, RL, Hageman, G. Earlyonset cerebellar ataxia with retained tendon reflexes: foot deformity in a first grade family member. Clin Neurol Neurosurg 1999;101(4):253–255.Google Scholar
8. Dyck, PJ, Lambert, EH. Lower motor and primary sensory neurondiseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. Arch Neurol 1968;18(6):619–625.Google Scholar
9. Gilliatt, RW, Thomas, PK. Extreme slowing of nerve conduction inperoneal muscular atrophy. Ann Phys Med 1957;15:104–106.Google Scholar
10. Lambert, EH. Clinical Examinations in Neurology. Philadelphia:W.B. Saunders, 1956:287–317.Google Scholar
11. Harding, AE, Thomas, PK. The clinical features of hereditary motor andsensory neuropathy types I and II. Brain 1980;103(2):259–280.CrossRefGoogle Scholar
12. Dyck, PJ, Oviatt, KF, Lambert, EH. Intensive evaluation of referredunclassified neuropathies yields improved diagnosis. AnnNeurol 1981;10(3):222–226.Google ScholarPubMed
13. Harding, AE, Thomas, PK. Autosomal recessive forms of hereditarymotor and sensory neuropathy. J Neurol Neurosurg Psychiatry 1980;43(8):669–678.Google Scholar
14. Bird, TD, Ott, J, Giblett, ER. Evidence for linkage of Charcot-Marie-Tooth neuropathy to the Duffy locus on chromosome 1. Am J Hum Genet 1982;34(3):388–394.Google Scholar
15. Stebbins, NB, Conneally, PM. Linkage of dominantly inheritedCharcot-Marie-Tooth neuropathy to the Duffy locus in an Indiana family. Am J Hum Genet 1982;34:195A.Google Scholar
16. Vance, JM, Nicholson, GA, Yamaoka, LH, et al. Linkage of Charcot-Marie-Tooth neuropathy type 1a to chromosome 17. Exp Neurol 1989;104(2):186–189.CrossRefGoogle ScholarPubMed
17. Chance, PF, Bird, TD, O’Connell, P, et al. Genetic linkage andheterogeneity in type I Charcot-Marie-Tooth disease (hereditary motor and sensory neuropathy type I). Am J Hum Genet 1990;47(6):915–925.Google Scholar
18. Hahn, AF, Brown, WF, Koopman, WJ, Feasby, TE. X-linkeddominant hereditary motor and sensory neuropathy. Brain 1990;113(Pt 5):1511–1525.Google Scholar
19. Krajewski, KM, Lewis, RA, Fuerst, DR, et al. Neurologicaldysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 2000;123(Pt 7):1516–1527.Google Scholar
20. Jetten, AM, Suter, U. The peripheral myelin protein 22 and epithelialmembrane protein family. Prog Nucleic Acid Res Mol Biol 2000;64:97–129.Google Scholar
21. Shapiro, L, Doyle, JP, Hensley, P, Colman, DR, Hendrickson, WA. Crystal structure of the extracellular domain from P0, the major structuralproteinof peripheralnervemyelin. Neuron 1996;17(3):435–449.Google Scholar
22. Scherer, SS, Deschenes, SM, Xu, YT, et al. Connexin32 is a myelin-related protein in the PNS and CNS. J Neurosci 1995;15(12):8281–8294.Google Scholar
23. Sahenk, Z, Chen, L, Mendell, JR. Effects of PMP22 duplication anddeletions on the axonal cytoskeleton. Ann Neurol 1999;45(1):16–24.3.0.CO;2-F>CrossRefGoogle ScholarPubMed
24. Warner, LE, Mancias, P, Butler, IJ, et al. Mutations in the earlygrowth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 1998;18:382–384.Google Scholar
25. Kamholz, J, Awatramani, R, et al. Regulation of myelin-specific gene expression. Relevance to CMT 1. Ann N Y Acad Sci 1999;883:91–108.Google Scholar
26. Bellone, E, Di Maria, E, Soriani, S, et al. A novel mutation (D305V)in the early growth response 2 gene is associated with severe Charcot-Marie-Tooth type 1 disease. Hum Mutat 1999;14(4):353–354.Google Scholar
27. Timmerman, V, De Jonghe, P, Ceuterick, C, et al. Novel missensemutation in the early growth response 2 gene associated with Dejerine-Sottas syndrome phenotype. Neurology 1999;52(9):1827–1832.Google Scholar
28. Schenone, A, Nobbio, L, Mandich, P, et al. Underexpression ofmessenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies. Neurology 1997;48:445–449.Google Scholar
29. Lenssen, PP, Gabreels-Festen, AA, Valentijn, LJ, et al. Hereditaryneuropathy with liability to pressure palsies. Phenotypic differences between patients with the common deletion and a PMP22 frame shift mutation. Brain 1998;121(Pt 8):1451–1458.Google Scholar
30. Nicholson, GA, Valentijn, LJ, Cherryson, AK, et al. A frame shiftmutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies [published erratum appears in Nat Genet 1994 May;7(1):113]. Nat Genet 1994;6(3):263–266.Google Scholar
31. Young, P, Wiebusch, H, Stogbauer, F, et al. A novel frameshiftmutation in PMP22 accounts for hereditary neuropathy with liability to pressure palsies. Neurology 1997;48(2):450–452.Google Scholar
32. Vallat, JM, Sindou, P, Preux, PM, et al. Ultrastructural PMP22expression in inherited demyelinating neuropathies. Ann Neurol 1996;39(6):813–817.Google Scholar
33. Gabriel, JM, Erne, B, Pareyson, D, et al. Gene dosage effects inhereditary peripheral neuropathy. Expression of peripheral myelin protein 22 in Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies nerve biopsies. Neurology 1997;49(6):1635–1640.Google Scholar
34. Yoshikawa, H, Nishimura, T, Nakatsuji, Y, et al. Elevated expressionof messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A . Ann Neurol 1994;35(4):445–450.CrossRefGoogle Scholar
35. Fabrizi , GM, Simonati, A, Morbin, M, et al. Clinical and pathologicalcorrelations in Charcot-Marie-Tooth neuropathy type 1A with the 17p11.2p12 duplication: a cross-sectional morphometric and immunohistochemical study in twenty cases . Muscle Nerve 1998;21(7):869–877.Google Scholar
36. Sturtz, FG, Latour, P, Mocquard, Y, et al. Clinical and electrophysio-logical phenotype of a homozygously duplicated Charcot-Marie-Tooth (type 1A) disease . Eur Neurol 1997;38(1):26–30.Google Scholar
37. Warner, LE, Hilz, MJ, Appel, SH, et al. Clinical phenotypes ofdifferent MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination . Neuron 1996;17(3):451–460.CrossRefGoogle Scholar
38. Wise, CA, Garcia, CA, Davis, SN, et al. Molecular analyses ofunrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMT1A duplication . Am J Hum Genet 1993;53(4):853–863.Google Scholar
39. Birouk, N, Gouider, R, Le Guern, E, et al. Charcot-Marie-Toothdisease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases . Brain 1997;120(Pt 5):813–823.CrossRefGoogle Scholar
40. Thomas, PK, Marques, W Jr, Davis, MB, et al. The phenotypicmanifestations of chromosome 17p11.2 duplication . Brain 1997;120(Pt 3):465–478.Google Scholar
41. Blair, IP, Nash, J, Gordon, MJ, Nicholson, GA. Prevalence and originof de novo duplications in Charcot-Marie-Tooth disease type 1A: first report of a de novo duplication with a maternal origin. Am J Hum Genet 1996;58(3):472–476.Google Scholar
42. Marrosu, MG, Vaccargiu, S, Marrosu, G, et al. A novel pointmutation in the peripheral myelin protein 22 (PMP22) gene associated with Charcot-Marie-Tooth disease type 1A. Neurology 1997;48(2):489–493.Google Scholar
43. Dyck, PJ, Gutrecht, JA, Bastron, JA, Karnes, WE, Dale, AJ. Histologic and teased-fiber measurements of sural nerve in disorders of lower motor and primary sensory neurons. Mayo Clin Proc 1968;43(2):81–123.Google Scholar
44. Hoogendijk, JE, De Visser, M, Bolhuis, PA, et al. Hereditary motorand sensory neuropathy type I: clinical and neurographical features of the 17p duplication subtype . Muscle Nerve 1994; 17(1):85–90.CrossRefGoogle Scholar
45. Killian, JM, Tiwari, PS, Jacobson, S, Jackson, RD, Lupski, JR. Longitudinal studies of the duplication form of Charcot-Marie-Tooth polyneuropathy. Muscle Nerve 1996;19(1):74–78.Google Scholar
46. Roy, EPd, Gutmann, L, Riggs, JE. Longitudinal conduction studiesin hereditary motor and sensory neuropathy type 1. Muscle Nerve 1989;12(1):52–55.Google Scholar
47. Kaku, DA, Parry, GJ, Malamut, R, Lupski, JR, Garcia, CA. Nerveconduction studies in Charcot-Marie-Tooth polyneuropathy associated with a segmental duplication of chromosome 17. Neurology 1993;43(9):1806–1808.Google Scholar
48. Garcia, A, Combarros, O, Calleja, J, Berciano, J. Charcot-Marie-Tooth disease type 1A with 17p duplication in infancy and early childhood: a longitudinal clinical and electrophysiologic study. Neurology 1998;50(4):1061–1067.Google Scholar
49. Nicholson , GA. Penetrance of the hereditary motor and sensoryneuropathy Ia mutation: assessment by nerve conduction studies. Neurology 1991;41(4):547–552.CrossRefGoogle Scholar
50. Wilbourn, AJ. Differentiating acquired from familial segmentaldemyelinating neuropathies by EMG. Electroencephalogr Clin Neurophysiol 1977;43:616A.Google Scholar
51. Lewis, RA, Sumner, AJ. The electrodiagnostic distinctions betweenchronic familial and acquired demyelinative neuropathies. Neurology 1982;32(6):592–596.CrossRefGoogle ScholarPubMed
52. Kaku, DA, Parry, GJ, Malamut, R, Lupski, JR, Garcia, CA. Uniformslowing of conduction velocities in Charcot-Marie-Tooth polyneuropathy type 1. Neurology 1993;43(12):2664–2667.Google Scholar
53. Lewis, RA, Sumner, AJ, Shy, ME. Electrophysiological features ofinherited demyelinating neuropathies: a reappraisal in the era of molecular diagnosis. Muscle Nerve 2000;23(10):1472–1487.3.0.CO;2-#>CrossRefGoogle ScholarPubMed
54. Oh, SJ, Chang, CW. Conduction block and dispersion in hereditarymotor and sensory neuropathy (abstract). Muscle Nerve. 1987;10:656A.Google Scholar
55. Hoogendijk, JE, de Visser, M, Bour, LJ, Jennekens, FG, Ongerboer, BW. Conduction block in hereditary motor and sensory neuropathy type I [letter]. Muscle Nerve 1992;15(4):520–521.Google ScholarPubMed
56. Dyck, PJ, Karnes, JL, Lambert, EH. Longitudinal study ofneuropathic deficits and nerve conduction abnormalities in hereditary motor and sensory neuropathy type 1. Neurology 1989;39(10):1302:1308.Google Scholar
57. Gabreels-Festen, AA, Joosten, EM, Gabreels, FJ, Jennekens, FG, Janssen-van Kempen, TW. Early morphological features in dominantly inherited demyelinating motor and sensory neuropathy (HMSN type I). J Neurol Sci 1992;107(2):145–154.Google Scholar
58. Behse, F, Buchthal, F. Peroneal muscular atrophy (PMA) and relateddisorders. II. Histological findings in sural nerves. Brain 1977;100(Pt 1):67–85.CrossRefGoogle Scholar
59. Ouvrier, RA, McLeod, JG, Conchin, TE. The hypertrophic forms ofhereditary motor and sensory neuropathy. A study of hypertrophic Charcot-Marie-Tooth disease (HMSN type I) and Dejerine-Sottas disease (HMSN type III) in childhood. Brain 1987;110(Pt 1):121–148.Google Scholar
60. Gabreels-Festen, AA, Bolhuis, PA, Hoogendijk, JE, et al. Charcot-Marie-Tooth disease type 1A: morphological phenotype of the 17pduplicationversusPMP22pointmutations. ActaNeuropathol 1995;90(6):645–649.Google Scholar
61. Dyck, PJ. Histologic measurements and fine structure of biopsiedsural nerve: normal, and in peroneal muscular atrophy, hypertrophic neuropathy, and congenital sensory neuropathy. Mayo Clin Proc 1966;41(11):742–774.Google Scholar
62. Dyck, PJ, Chance, P, Lebo, R, Carney, JA. Hereditary motor andsensory neuropathies. InDyck, PJ, Thomas, PK, eds. Peripheral Neuropathy. 3 Ed. Philadelphia:W. B. Saunders; 1993;1094–1136.Google Scholar
63. Gabreels-Festen, A, Wetering, RV. Human nerve pathology causedby different mutational mechanisms of the PMP22 gene. Ann NY Acad Sci 1999;883:336–343.Google Scholar
64. Nukada, H, Dyck, PJ, Karnes, JL. Thin axons relative to myelinspiral length in hereditary motor and sensory neuropathy, type I. Ann Neurol 1983;14(6):648–655. Google Scholar
65. Nukada, H, Dyck, PJ. Decreased axon caliber and neurofilaments inhereditary motor and sensory neuropathy, type I. Ann Neurol 1984;16(2):238–241.Google Scholar
66. Latour, P, Blanquet, F, Nelis, E, et al. Mutations in the myelin proteinzero gene associated with Charcot-Marie-Tooth disease type 1B. Hum Mutat 1995;6(1):50–54.CrossRefGoogle Scholar
67. Bird, TD, Kraft, GH, Lipe, HP, Kenney, KL, Sumi, SM. Clinical andpathological phenotype of the original family with Charcot-Marie-Tooth type 1B:a 20-year study. Ann Neurol 1997;41(4):463–469.CrossRefGoogle Scholar
68. Plante-Bordeneuve, V, Guiochon-Mantel, A, Lacroix, C, Lapresle, J, Said, G. The Roussy-Levy family:from the original description to the gene. Ann Neurol 1999;46(5):770–773.Google Scholar
69. Gabreels-Festen, AA, Hoogendijk, JE, Meijerink, PH, et al. Twodivergent types of nerve pathology in patients with different P0 mutations in Charcot-Marie-Tooth disease. Neurology 1996;47(3):761–765.CrossRefGoogle Scholar
70. Filbin, MT, Walsh, FS, Trapp, BD, Pizzey, JA, Tennekoon, GI. Role ofmyelin P0 protein as a homophilic adhesion molecule. Nature 1990;344(6269):871–872.Google Scholar
71. Roussy, G, Lé;vy, G. Sept cas d’une maladie familiale particulière:troubles de la marche, pieds bots et aré;flexie tendineuse gé; né; ralisé e, avec, accessoirement, légére maladresse des mains. Rev Neurol 1926;1:427–450.Google Scholar
72. Senderek, J, Hermanns, B, Bergmann, C, et al. X-linked dominantCharcot-Marie-Tooth neuropathy:clinical, electrophysio-logical, and morphological phenotype in four families with different connexin32 mutations(1). J Neurol Sci 1999;167(2):90–101.Google Scholar
73. Dalakas , MC, Teravainen, H, Engel, WK. Tremor as a feature ofchronic relapsing and dysgammaglobulinemic polyneuropa-thies. Incidence and management. Arch Neurol 1984;41(7):711–714.Google Scholar
74. Pedersen, SF, Pullman, SL, Latov, N, Brannagan, TH, 3rd.Physiological tremor analysis of patients with anti-myelin-associated glycoprotein associated neuropathy and tremor. Muscle Nerve 1997;20(1):38–44.3.0.CO;2-I>CrossRefGoogle ScholarPubMed
75. Timmerman, V, De Jonghe, P, Spoelders, P, et al. Linkage andmutation analysis of Charcot-Marie-Tooth neuropathy type 2 families with chromosomes 1p35-p36 and Xq13. Neurology 1996;46(5):1311–1318.Google Scholar
76. Ben Othmane, K, Middleton, LT, Loprest, LJ, et al. Localization of agene (CMT2A) for autosomal dominant Charcot-Marie- Tooth disease type 2 to chromosome 1p and evidence of genetic heterogeneity. Genomics 1993;17(2):370–375.Google Scholar
77. Kwon, JM, Elliott, JL, Yee, WC, et al. Assignment of a secondCharcot-Marie-Tooth type II locus to chromosome 3q. Am J Hum Genet 1995;57(4):853–858.Google ScholarPubMed
78. De Jonghe, P, Timmerman, V, FitzPatrick, D, et al. Mutilatingneuropathic ulcerations in a chromosome 3q13-q22 linked Charcot-Marie-Tooth disease type 2B family. J Neurol Neurosurg Psychiatry 1997;62(6):570–573.CrossRefGoogle Scholar
79. Ionasescu, V, Searby, C, Sheffield, VC, et al. Autosomal dominantCharcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D). Hum Mol Genet 1996;5(9):1373–1375.Google Scholar
80. Mersiyanova, IV, Perepelov, AV, Polyakov, AV, et al. A new variantof Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet 2000;67(1):37–46.CrossRefGoogle Scholar
81. Dyck, PJ, Litchy, WJ, Minnerath, S, et al. Hereditary motor andsensory neuropathy with diaphragm and vocal cord paresis. Ann Neurol 1994;35(5):608–615.CrossRefGoogle Scholar
82. Friedman, HC, Jelsma, TN, Bray, GM, Aguayo, AJ. A distinct patternof trophic factor expression in myelin-deficient nerves of Trembler mice:implications for trophic support by Schwann cells. J Neurosci 1996;16(17):5344–5350.Google Scholar
83. Marrosu, MG, Vaccargiu, S, Marrosu, G, et al. Charcot-Marie-Toothdisease type 2 associated with mutation of the myelin protein zero gene. Neurology 1998;50(5):1397–1401.Google Scholar
84. Chapon, F, Latour, P, Diraison, P, Schaeffer, S, Vandenberghe A.Axonal phenotype of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene. J Neurol Neurosurg Psychiatry 1999;66(6):779–782.CrossRefGoogle Scholar
85. De Jonghe, P, Timmerman, V, Ceuterick, C, et al. The Thr124Metmutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. Brain 1999;122(Pt 2):281–290.Google Scholar
86. Harding, AE, Thomas, PK. Hereditary distal spinal muscularatrophy. A report on 34 cases and a review of the literature. J Neurol Sci 1980;45(2–3):337–348.Google Scholar
87. Nicholson, G, Nash, J. Intermediate nerve conduction velocitiesdefine X-linked Charcot-Marie- Tooth neuropathy families. Neurology 1993;43(12):2558–2564.CrossRefGoogle ScholarPubMed
88. Rouger, H, LeGuern, E, Birouk, N, et al. Charcot-Marie-Toothdisease with intermediate motor nerve conduction velocities:characterization of 14 Cx32 mutations in 35 families. Hum Mutat 1997;10(6):443–452.3.0.CO;2-E>CrossRefGoogle Scholar
89. Birouk, N, LeGuern, E, Maisonobe, T, et al. X-linked Charcot-Marie-Tooth disease with connexin 32 mutations:clinical and electrophysiologic study. Neurology 1998;50(4):1074–1082.CrossRefGoogle Scholar
90. Hahn, AF, Bolton, CF, White, CM, et al. Genotype/phenotypecorrelations in X-linked dominant Charcot-Marie- Tooth disease. Ann N Y Acad Sci 1999;883:366–382.Google Scholar
91. Berciano, J, Combarros, O, Figols, J, et al. Hereditary motor andsensory neuropathy type II. Clinicopathological study of a family. Brain 1986;109(Pt 5):897–914.Google Scholar
92. Vogel, P, Gabriel, M, Goebel, HH, Dyck, PJ. Hereditary motorsensory neuropathy type II with neurofilament accumulation:new finding or new disorder?. Ann Neurol 1985;17(5):455–461.Google Scholar
93. Silander, K, Meretoja, P, Pihko, H, et al. Screening for connexin 32mutations in Charcot-Marie-Tooth disease families with possible X-linked inheritance. Hum Genet 1997;100(3–4):391–397.Google Scholar
94. Bergoffen, J, Scherer, SS, Wang, S, et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 1993;262(5142):2039–2042.CrossRefGoogle ScholarPubMed
95. Meggouh, F, Benomar, A, Rouger, H, et al. The first de novomutation of the connexin 32 gene associated with X-linked Charcot-Marie-Tooth disease. J Med Genet 1998;35(3):251–252.CrossRefGoogle Scholar
96. Niewiadomski, LA, Kelly, TE. X-linked Charcot-Marie-Toothdisease: molecular analysis of interfamilial variability. Am J Med Genet 1996;66(2):175–178.Google Scholar
97. Ionasescu, VV, Trofatter, J, Haines, JL, Ionasescu, R, Searby, C. Mapping of the gene for X-linked dominant Charcot-Marie-Tooth neuropathy. Neurology 1992;42(4):903–908.Google Scholar
98. Scherer , SS, Xu, YT, Nelles, E, et al. Connexin32-null mice developdemyelinating peripheral neuropathy. Glia 1998;24(1):8–20.Google Scholar
99. Bahr, M, Andres, F, Timmerman, V, et al. Central visual, acoustic,and motor pathway involvement in a Charcot-Marie-Tooth family with an Asn205Ser mutation in the connexin 32 gene. J Neurol Neurosurg Psychiatry 1999;66(2):202–206.Google Scholar
100. Hahn, AF, Ainsworth, PJ, Naus, CC, Mao, J, Bolton, CF. Clinical andpathological observations in men lacking the gap junction protein connexin 32. Muscle Nerve 2000;999(9):S39–S48.Google Scholar
101. Lewis, RA, Shy, ME. Electrodiagnostic findings in CMTX:adisorder of the Schwann cell and peripheral nerve myelin. Ann N Y Acad Sci 1999;883:504–507.Google Scholar
102. Tabaraud, F, Lagrange, E, Sindou, P, et al. Demyelinating X-linkedCharcot-Marie-Tooth disease:unusual electrophysiological findings. Muscle Nerve 1999;22:1442–1447.Google Scholar
103. Gutierrez, A, England, JD, Sumner, AJ, e tal. Unusualelectrophysiological findings in X-linked dominant Charcot-Marie-Tooth disease. Muscle Nerve 2000;23(2):182–188.Google Scholar
104. Sander, S, Nicholson, GA, Ouvrier, RA, McLeod, JG, Pollard, JD. Charcot-Marie-Tooth disease:histopathological features of the peripheral myelin protein (PMP22) duplication (CMT 1A) and connexin32 mutations (CMTX1). Muscle Nerve 1998;21(2):217–225.3.0.CO;2-E>CrossRefGoogle Scholar
105. Sahenk, Z, Chen, L. Abnormalities in the axonal cytoskeletoninduced by a connexin32 mutation in nerve xenografts. J Neurosci Res 1998;51(2):174–184.Google Scholar
106. Davies, DM. Recurrent peripheral-nerve palsies in a family. Lancet 1954;2:226–268.Google Scholar
107. Behse, F, Buchthal, F, Carlsen, F, Knappeis, GG. Hereditaryneuropathy with liability to pressure palsies. Electrophysio-logical and histopathological aspects. Brain 1972;95(4):777–794.Google Scholar
108. Chance, PF, Alderson, MK, Leppig, KA, et al. DNA deletionassociated with hereditary neuropathy with liability to pressure palsies. Cell 1993;72(1):143–151.CrossRefGoogle Scholar
109. Mariman, EC, Gabreels-Festen, AA, van Beersum, SE, et al. Prevalence of the 1.5-Mb 17p deletion in families with hereditary neuropathy with liability to pressure palsies. AnnNeurol 1994;36(4):650–655.Google ScholarPubMed
110. Meretoja, P Silander, K, Kalimo, H, et al. Epidemiology of hereditaryneuropathy with liability to pressure palsies (HNPP) in south western Finland. Neuromuscul Disord 1997;7(8):529–532.Google Scholar
111. Tyson, J, Malcolm, S, Thomas, PK, Harding, AE. Deletions ofchromosome 17p11.2 in multifocal neuropathies. Ann Neurol 1996;39(2):180–186.Google Scholar
112. Pareyson, D, Scaioli, V, Taroni, F, et al. Phenotypic heterogeneity inhereditary neuropathy with liability to pressure palsies associated with chromosome 17p11.2-12 deletion. Neurology 1996;46(4):1133–1137.Google Scholar
113. Gil-Neciga, E, Franco, E, Sanchez, A, et al. Recurrent familialbrachial plexopathy as the only clinical expression of neuropathy with susceptibility to pressure. Neurologia 2000;15(4):177–181.Google Scholar
114. Mouton , P, Tardieu, S, Gouider, R, et al. Spectrum of clinical andelectrophysiologic features in HNPP patients with the 17p11.2 deletion. Neurology 1999;52(7):1440–1446.Google Scholar
115. Windebank, AJ, Schenone, A, Dewald, GW. Hereditary neuropathywith liability to pressure palsies and inherited brachial plexus neuropathy--two genetically distinct disorders. Mayo Clin Proc. 1995;70(8):743–746.Google Scholar
116. Pellegrino, JE, George, RA, Biegel, J, et al. Hereditary neuralgicamyotrophy: evidence for genetic homogeneity and mapping to chromosome 17q25. Hum Genet 1997;101(3):277–283.Google Scholar
117. Stogbauer, F, Young, P, Timmerman, V, et al. Refinement of thehereditary neuralgic amyotrophy (HNA) locus to chromosome 17q24-q25. Hum Genet. 1997;99(5):685–687.Google Scholar
118. Le Forestier, N, LeGuern, E, Coullin, P, et al. Recurrentpolyradiculoneuropathy with the 17p11.2 deletion. Muscle Nerve 1997;20(9):1184–1186.Google Scholar
119. Crum, BA, Sorenson, EJ, Abad, GA, Dyck, PJ. Fulminant case ofhereditary neuropathy with liability to pressure palsy. MuscleNerve 2000;23(6):979–983.Google ScholarPubMed
120. Magistris, MR, Roth, G. Long-lasting conduction block inhereditary neuropathy with liability to pressure palsies. Neurology 1985;35(11):1639–1641.Google Scholar
121. Uncini , A, Di Guglielmo, G, Di Muzio, A, et al. Differentialelectrophysiological features of neuropathies associated with 17p11.2 deletion and duplication. Muscle Nerve 1995;18(6):628–635.Google Scholar
122. Amato, AA, Gronseth, GS, Callerame, KJ, et al. Tomaculousneuropathy:a clinical and electrophysiological study in patients with and without 1.5-Mb deletions in chromosome 17p11.2. Muscle Nerve 1996;19(1):16–22.Google Scholar
123. Andersson, PB, Yuen, E, Parko, K, So, YT. Electrodiagnostic featuresof hereditary neuropathy with liability to pressure palsies. Neurology 2000;54(1):40–44.Google Scholar
124. Verhagen, WI, Gabreels-Festen, AA, van Wensen, PJ, et al. Hereditary neuropathy with liability to pressure palsies:a clinical, electroneurophysiological and morphological study. J Neurol Sci 1993;116(2):176–184.Google Scholar
125. Gouider, R, LeGuern, E, Gugenheim, M, et al. Clinical, electro-physiologic, and molecular correlations in 13 families with hereditary neuropathy with liability to pressure palsies and a chromosome 17p11.2 deletion. Neurology 1995;45(11):2018–2023.Google Scholar
126. Madrid, R, Bradley, WG. The pathology of neuropathies with focalthickening of the myelin sheath (tomaculous neuropathy). J Neurol Sci 1975;25:415–448.Google Scholar
127. Yoshikawa, H, Dyck, PJ. Uncompacted inner myelin lamellae ininherited tendency to pressure palsy. J Neuropathol Exp Neurol 1991;50(5):649–657.Google Scholar
128. Behse, F, Buchthal, F, Carlsen, F, Knappeis, GG. Conduction andhistopathology of the sural nerve in hereditary neuropathy with liability to pressure palsies. In: Desmedt, JE, ed. New Developments in Electromyography and Clinical Neuro-physiology. Basel:S. Karger;1973;286.Google Scholar
129. Hayasaka, K, Himoro, M, Sawaishi, Y, et al. De novo mutation of themyelin P0 gene in Dejerine-Sottas disease (hereditary motor andsensory neuropathy type III). Nat Genet 1993;5(3):266–268.Google Scholar
130. Rautenstrauss, B, Nelis, E, Grehl, H, Pfeiffer, RA, Van Broeckhoven, C. Identification of a de novo insertional mutation in P0 in a patient with a Dejerine-Sottas syndrome (DSS) phenotype. Hum Mol Genet 1994;3(9):1701–1702.Google Scholar
131. Roa, BB, Dyck, PJ, Marks, HG, Chance, PF, Lupski, JR. Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene. Nat Genet 1993;5(3):269–273.Google Scholar
132. Marques W, Jr, Thomas, PK, Sweeney, MG, Carr, L, Wood, NW. Dejerine-Sottas neuropathy and PMP22 point mutations: a new base pair substitution and a possible “hot spot” on Ser72. Ann Neurol 1998;43(5):680–683.Google Scholar
133. Killian, JM, Kloepfer, HW. Homozygous expression of a dominantgene for Charcot-Marie-Tooth neuropathy. Ann Neurol 1979;5(6):515–522.Google Scholar
134. Ikegami, T, Nicholson, G, Ikeda, H, et al. A novel homozygousmutation of the myelin P0 gene producing Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Biochem Biophys Res Commun 1996;222(1):107–110.Google Scholar
135. Benstead, TJ, Kuntz, NL, Miller, RG, Daube, JR. The electrophysio-logic profile of Dejerine-Sottas disease (HMSN III). Muscle Nerve 1990;13(7):586–592.Google Scholar
136. Gabreels-Festen, AA, Gabreels, FJ, Jennekens, FG, Janssen-vanKempen, TW. The status of HMSN type III. Neuromusc Disord. 1994;4(1):63–69.Google Scholar
137. Lyon, G. Ultrastructural study of a nerve biopsy from a case of earlyinfantile chronic neuropathy. Acta Neuropathol 1969;13(2):131–142.Google Scholar
138. Joosten, E, Gabreels, F, Gabreels-Festen, A, et al. Electron-microscopic heterogeneity of onion-bulb neuropathies of the Dejerine-Sottas type. Two patients in one family with the variant described by Lyon (1969). Acta Neuropathol (Berl) 1974;27(2):105–118.CrossRefGoogle ScholarPubMed
139. Kennedy, WR, Sung, JH, Berry, JF. A case of congenitalhypomyelination neuropathy. Clinical, morphological, andchemical studies. Arch Neurol 1977;34:337–345.Google Scholar
140. Guzzetta, F, Ferriere, G, Lyon, G. Congenital hypomyelinationpolyneuropathy. Pathological findings compared with polyneuropathies starting later in life. Brain 1982;105(Pt2):395–416.Google Scholar
141. Ben Othmane, K, Hentati, F, Lennon, F, et al. Linkage of a locus(CMT4A) for autosomal recessive Charcot-Marie-Tooth diseaseto chromosome 8q. Hum Mol Genet 1993;2(10):1625–1628.Google Scholar
142. Bolino, A, Brancolini, V, Bono, F, et al. Localization of a generesponsible for autosomal recessive demyelinating neuropathy with focally folded myelin sheaths to chromosome 11q23 by homozygosity mapping and haplotype sharing. Hum Mol Genet 1996;5(7):1051–1054.Google Scholar
143. LeGuern, E, Guilbot, A, Kessali, M, et al. Homozygosity mapping ofan autosomal recessive form of demyelinating Charcot-Marie-Tooth disease to chromosome 5q23-q33. Hum Mol Genet 1996;5(10):1685–1688.Google Scholar
144. Gabreels-Festen, A, van Beersum, S, Eshuis, L, et al. Study on thegene and phenotypic characterisation of autosomal recessive demyelinating motor and sensory neuropathy (Charcot-Marie-Tooth disease) with a gene locus on chromosome 5q23-q33. JNeurol Neurosurg Psychiatry 1999;66(5):569–574.Google Scholar
145. Kalaydjieva, L, Hallmayer, J, Chandler, D, et al. Gene mapping inGypsies identifies a novel demyelinating neuropathy on chromosome 8q24. Nat Genet 1996;14(2):214–217.Google Scholar
146. Delague, V, Bareil, C, Tuffery, S, et al. Mapping of a new locus forautosomal recessive demyelinating Charcot-Marie-Tooth disease to 19q13.1-13.3 in a large consanguineous Lebanese family:exclusion of MAG as a candidate gene. Am J Hum Genet 2000;67(1):236–243. Google Scholar
147. Bouhouche, A, Benomar, A, Birouk, N, et al. A locus for an axonalform of autosomal recessive Charcot-Marie-Tooth disease maps to chromosome 1q21.2-q21.3. Am J Hum Genet 1999;65(3):722–727.Google Scholar
148. Leal, A, Morera, B, Del Valle, G, et al. A Second Locus for an AxonalForm of Autosomal Recessive Charcot-Marie- Tooth Disease Maps to Chromosome 19q13.3. Am J Hum Genet 2000;68(1).Google Scholar
149. Quattrone, A, Gambardella, A, Bono, F, et al. Autosomal recessivehereditary motor and sensory neuropathy with focally folded myelin sheaths:clinical, electrophysiologic, and genetic aspects of a large family. Neurology 1996;46:1318–1324.Google Scholar
150. Vallat, JM, Gil, R, Leboutet, MJ, Hugon, J, Moulies, D. Congenitalhypo- and hypermyelination neuropathy. Two cases. Acta Neuropathol 1987;74(2):197–201.Google Scholar
151. Ohnishi, A, Murai, Y, Ikeda, M, et al. Autosomal recessive motor andsensory neuropathy with excessive myelin outfolding. Muscle Nerve 1989;12(7):568–575.Google Scholar
152. Gabreels-Festen, AA, Joosten, EM, Gabreels, FJ, et al. Congenitaldemyelinating motor and sensory neuropathy with focally folded myelin sheaths. Brain 1990;113:1629–1643.Google Scholar
153. Sabatelli, M, Mignogna, T, Lippi, G, et al. Autosomal recessive hyper-myelinating neuropathy. Acta Neuropathol 1994;87(4):337–342.Google Scholar
154. Schenone, A, Abbruzzese, M, Uccelli, A, et al. Hereditary motor andsensory neuropathy with myelin outfolding: clinical, genetic and neuropathological study of three cases [published erratum appears in J Neurol Sci 1994 Sep;125(2):215]. J Neurol Sci 1994;122(1):20–27.Google Scholar
155. Barbieri, F, Santangelo, R, Capparelli, G, Ciccarelli, A, Crisci, C. Autosomal recessive motor and sensory neuropathy with excessive myelin outfolding in two siblings. Can J Neurol Sci 1994;21(1):29–33.Google Scholar
156. Kessali, M, Zemmouri, R, Guilbot, A, et al. A clinical,electrophysiologic, neuropathologic, and genetic study of two large Algerian families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease. Neurology. 1997;48(4):867–873.Google Scholar
157. Umehara, F, Takenaga, S, Nakagawa, M, et al. Dominantly inheritedmotor and sensory neuropathy with excessive myelin foldingcomplex. Acta Neuropathol 1993;86(6):602–608.Google Scholar
158. Nakagawa, M, Suehara, M, Saito, A, et al. A novel MPZ genemutation in dominantly inherited neuropathy with focally folded myelin sheaths. Neurology 1999;52(6):1271–1275.Google Scholar
159. Ring, HZ, Chang, H, Guilbot, A, et al. The human neuregulin-2(NRG2) gene:cloning, mapping and evaluation as a candidate for the autosomal recessive form of Charcot-Marie-Tooth disease linked to 5q. Hum Genet 1999;104(4):326–332.Google Scholar